Health Technology/clinical-trials

Phase III Trial Opens: Exercogs® AR Platform vs Conventional Training for Dementia Prevention — What Clinicians Need to Know

247 Health News Editorial

·

18 Apr 2026

·

4 min read

·clinical-trials

New randomised trial evaluates Exercogs®, an augmented reality platform combining cognitive, physical, and social training for dementia prevention in at-risk adults 55+. Results could reshape digital therapeutic approaches to cognitive decline prevention.

Originally reported by ClinicalTrials.gov

References

  1. 1.García-Betances, R. I., Jiménez-Mixco, V., Arredondo, M. T., & Cabrera-Umpiérrez, M. F. (2015). A succinct overview of virtual reality technology use in Alzheimer's disease. Frontiers in Aging Neuroscience, 7, 80. https://doi.org/10.3389/fnagi.2015.00080
  2. 2.Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., Costafreda, S. G., Dias, A., Fox, N., Gitlin, L. N., Howard, R., Kales, H. C., Kivimäki, M., Larson, E. B., Ogunniyi, A., ... Mukadam, N. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet, 404(10452), 572-628. https://doi.org/10.1016/S0140-6736(24)01296-0
  3. 3.Moll van Charante, E. P., Richard, E., Eurelings, L. S., van Dalen, J. W., Ligthart, S. A., van Bussel, E. F., Hoevenaar-Blom, M. P., & van Gool, W. A. (2016). Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. The Lancet, 388(10046), 797-805. https://doi.org/10.1016/S0140-6736(16)30950-3
  4. 4.Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., Lindström, J., Mangialasche, F., Paajanen, T., Pajala, S., Peltonen, M., Rauramaa, R., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., ... Kivipelto, M. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet, 385(9984), 2255-2263. https://doi.org/10.1016/S0140-6736(15)60461-5
  5. 5.Oliosi, E. (2024). Exercogs®: Efficacy of a Multidomain Digital Therapeutic Solution for Preventing Cognitive Decline in Adults Aged ≥55 With Modifiable Risk Factors - Randomized Controlled Trial. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07530315
  6. 6.World Health Organization. (2023). Dementia: Key Facts. WHO Fact Sheets. https://www.who.int/news-room/fact-sheets/detail/dementia
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service